pital
Welcome to the 31st Annual Enterprise Awards
The 2024 Enterprise Awards celebrate innovation in technology, life sciences, and investment with a live awards program that honors all of our Finalists and announces our Winners.
NAVIGATION
PACT’s Enterprise Awards is a dazzling celebration of groundbreaking innovation in technology, life sciences, and investment in the Greater Philadelphia Region. In a brief awards program that transcends the ordinary, we honor the trailblazing Finalists who have redefined the future. Brace yourselves for the unveiling of the ultimate Winners – the visionaries who have set new benchmarks in excellence – and then join your fellow attendees and industry leaders for an evening of connecting over delicious drinks and tasty treats in a fun outdoor reception.
See the photos from 2023’s awards ceremony and reception.
2024 Finalists
Hear from our finalists about their roads to success!
Life Sciences & Healthcare Startup
Code Biotherapeutics
iECURE – Winner
Trialbee
Sponsors: Blank Rome
Technology Startup
CareNostics
Mural Health Technologies – Winner
Red Vector
Sponsor: Troutman Pepper
Technology Investment Deal
Qlik – Winner
Tendo
Transcend
Sponsor: Comcast Business and JPMorgan
Life Sciences & Healthcare Emerging
Adaptimmune
BioAnalysis
Imvax – Winner
Sponsor: RSM
Technology Emerging
Burro
Cesium
DrayNow – Winner
Sponsors: Fox Rothschild and Broadpath
Life Sciences & Healthcare CEO
Just In Time GCP, Donna Dorozinsky
Incyte, Herve Hoppenot – Winner
Myonex, James Lovett
Sponsors: EY and Morgan Lewis
Technology CEO
Curotec, Brian Dainis
Electro Soft, Karla Trotman
Unilog, Suchit Bachalli – Winner
Sponsor: Cozen O’Connor
Healthcare Innovator
AscellaHealth
Cabaletta Bio – Winner
Carisma Therapeutics
Sponsor: Independence Blue Cross
Life Sciences & Healthcare Investment Deal
Harmony Biosciences
Mineralys – Winner
SK pharmteco
Sponsor: Bank of America
Sponsors
Title Sponsor
Judging Partner
AWARD SPONSORS
EVENT SPONSORS
Judges
LEAD JUDGE
Rick Riegel
Chairman
ActiGraph and Deerfield
Technology Judging Panel Oversight
Andrew Cherry
Partner
KPMG
Life Sciences & Healthcare Judging Panel Oversight
Jennifer Strong
Partner
KPMG
Tom Koncsics
Partner
KPMG
Technology Judges
Suchit Bachalli
Chief Executive Officer
Unilog
Mike Bachman
Global Architect & Principal Technologist
Boomi
Sean Dowling
Partner
Osage Partners
Alex King
Co-Managing Partner
Plain Sight Capital
Rick Nucci
CEO
Guru
Sneha Shah
EVP New Business Ventures
SEI
John Viglione
CEO
Quantumreg.tech
Kweli Washington
COO
Piano Software
Mark Weinstein
Chairman of Board of Directors
Strategikon Pharma
Life Sciences & Healthcare Judges
Tom Anderson
Former CEO
SwanBio
Mike DeFeo Jr.
Vice President, Life Sciences Commercial Banking
J.P Morgan Securities
Gerianne (Gerie) DiPiano
Chief Executive Officer
FemmePharma
Tiara Durham
Director, New Ventures
University City Science Center
Audrey Greenberg
Co-Founder & Chief Business Officer
Center for Breakthrough Medicines
Eric Heil
Managing Partner
Medical Excellence Capital
Lisa Jordan, MBA, MSE
Vice President Entrepreneurship & Innovation
CHOP
Jackie Hollenbach
Vice President, Research and Development
Teleflex
Joan Lau
CEO
Spirovant Sciences
Matthew Reber
Partner
1315 Capital
Bill Rhoda
General Partner & Chief Innovation Officer
Runway Healthcare
Award Criteria
To view the Enterprise Awards applications, please click on each award heading below.
The deadline for nominations was Friday, November 17th.
Healthcare Innovator
Sponsor: Independence Blue Cross
Criteria:
- The nominee can be a company, researcher, or investor providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- The Nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowing costs.
- The Nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth or adoption.
- The nominee should be able to demonstrate return on investment or clinical impact of its solution.
- The nominee can be in any sector (technology, life sciences, investment, health care delivery, etc.), but must be serving the healthcare industry in Greater Philadelphia.
Life Sciences & Healthcare Startup
Sponsors: Blank Rome
Criteria:
- Company must have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2020, and December 31, 2023.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Discuss product innovation including unmet market need and how that is uniquely addressed by your product/service.
- Discuss the management team and its record of achieving success.
- Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
- Describe the R&D investment strategy.
- What did the company do to overcome challenges in financing, development, or commercialization?
Life Sciences & Healthcare CEO
Sponsors: EY and Morgan Lewis
Criteria: Individual’s background and the company’s success to date.
- Company must be based in the region and their company must have their HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
- CEO must be in her/his position for at least 2 years.
Key Considerations:
- CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
- Leadership and impact in industry and/or market.
- Ability to attract and retain talented resources.
- Company milestones including financial accomplishments and a strategy for continued company success.
- Community/industry involvement.
- Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.
- Ability to attract and retain talented resources.
Life Sciences & Healthcare Emerging
Sponsors: RSM
Criteria:
- Company must have been in operation beginning on January 1, 2020. The Company should have no more than 8 years of operating results since its founding.
- Must have sales, grants, or licensing fees.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Describe product or service, including proprietary applications or other competitive advantage.
- The impact on the clinical problem this product or innovation is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
- Company milestones including strategic decisions made by the management team that led to growth in revenues and/or earnings, corporate collaborations, or license deals (e.g. ability to raise capital, strategy to achieve break even, ability to realize high gross margins, etc.).
Life Sciences & Healthcare Investment Deal
Sponsor: TBA
Criteria:
- Deal must have been fully executed between November 1, 2022, and October 31, 2023.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees and consultants must be based in the region.
- Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.
Key Considerations:
- Realized returns for the investors and management.
- EBITDA margin and revenue growth.
- Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
- Company performance prior to transaction.
- How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.
Technology Startup
A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.
Sponsors: Troutman Pepper
Criteria:
- Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2020, and December 31, 2023.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Product or service innovation including market need or assessment.
- Potential for significant growth.
- The management team and its record of achieving success.
- A demonstration of success such as significant milestones, raising capital, and revenue.
Technology CEO
A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.
Sponsor: TBA
Criteria:
- Individual’s background and the company’s success to date.
- CEO must be based in the region and their company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
- CEO must be in her/his position for at least 2 years.
Key Considerations:
- CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
- Leadership and impact in industry and/or market.
- Ability to attract and retain talented resources.
- Company milestones including financial accomplishments and a strategy for continued company success.
- Community/industry involvement.
- Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the technology industry in the region.
Technology Investment Deal
Sponsor: JPMorgan
Criteria:
- Deal must have been fully executed between November 1, 2022, and October 31, 2023.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees and consultants must be based in the region.
- Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.
Key Considerations:
- Realized returns for the investors and management.
- EBITDA margin and revenue growth.
- Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
- Company performance prior to transaction.
- How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.
Technology Emerging
A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.
Sponsors: TBA
Criteria:
- Company must have been in operation before January 1, 2020. Revenues must be less than $50 million. If revenues are projected to exceed $50 million in 2023, please complete the Technology Company application.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Product or service innovation, including proprietary technology or other advantage.
- Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
- Strength of management team including ability to raise capital.
- Demonstration of a sustainable and scalable business model.